Diabetes research in Europe is getting a $10 million boost, thanks to a fund set up by three organizations.
The new European Diabetes Research Program will support ongoing treatment and prevention research by awarding grants of more than $85,000 to scientists studying Type I and II diabetes.
Partners in the fund — The European Association for the Study of Diabetes, the Juvenile Diabetes Foundation and pharmaceutical giant Novo Nordisk A/S — hope the grants will bolster diabetes research in Europe, which suffers from lack of funding.
Dr. John Nerup, president of the European Diabetes Research Program, says Europe loses many young researchers to the U.S., where spending on diabetes research totals about $1 billion a year.
Nerup called on the European Union to increase funding for the study of the disease.
“There are two natural partners missing from this announcement: the EU and national governments,” he says. “It is the intent of the partnership to move in that direction. These countries are going to start feeling the heat on their budgets as the prevalence of diabetes continues to grow.”